Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guixia Wang

Showing results (161-170 of 258) with videos related to

Pageof 26
Sort By:
Genomics|March 11, 2021
Complete chloroplast genome sequencing of ten wild Fragaria species in China provides evidence for phylogenetic evolution of FragariaJian Sun, Rui Sun, Huabo Liu, et al.
Journal of Hepatology|December 21, 2024
Safety and efficacy of GLP-1/FGF21 dual agonist HEC88473 in MASLD and T2DM: A randomized, double-blind, placebo-controlled studyLin Xiang, Guixia Wang, Yulei Zhuang, et al.
Journal of Affective Disorders|November 28, 2022
Protective role of antioxidant supplementation for depression and anxiety: A meta-analysis of randomized clinical trialsHuan Wang, Mengdi Jin, Mengtong Xie, et al.
Journal of Diabetes|July 23, 2014
Evaluation of different obesity indices as predictors of type 2 diabetes mellitus in a Chinese populationXianchao Xiao, Yujia Liu, Chenglin Sun, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 16, 2022
LncRNA Osilr9 coordinates promoter DNA demethylation and the intrachromosomal loop structure required for maintaining stem cell pluripotencyYanbo Zhu, Zi Yan, Changhao Fu, et al.
Journal of Diabetes Investigation|May 17, 2016
Ideal glycated hemoglobin cut-off points for screening diabetes and prediabetes in a Chinese populationYujia Liu, Xianchao Xiao, Chenglin Sun, et al.
Frontiers in Endocrinology|September 26, 2022
Development and validation of a nomogram for assessing risk of isolated high 2-hour plasma glucoseKan Sun, Xianchao Xiao, Lili You, et al.
Diabetes Care|November 9, 2023
Efficacy and Safety of Mazdutide in Chinese Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Phase 2 TrialBo Zhang, Zhifeng Cheng, Ji Chen, et al.
The Lancet. Diabetes & Endocrinology|May 9, 2018
Dorzagliatin monotherapy in Chinese patients with type 2 diabetes: a dose-ranging, randomised, double-blind, placebo-controlled, phase 2 studyDalong Zhu, Shenglian Gan, Yu Liu, et al.
Journal of Epidemiology and Community Health|January 8, 2022
Association of education levels with the risk of hypertension and hypertension control: a nationwide cohort study in Chinese adultsKan Sun, Diaozhu Lin, Mian Li, et al.
Pageof 26

Showing results (161-170 of 258) with videos related to

Sort By:
Pageof 26
Genomics|March 11, 2021
Complete chloroplast genome sequencing of ten wild Fragaria species in China provides evidence for phylogenetic evolution of FragariaJian Sun, Rui Sun, Huabo Liu, et al.
Journal of Hepatology|December 21, 2024
Safety and efficacy of GLP-1/FGF21 dual agonist HEC88473 in MASLD and T2DM: A randomized, double-blind, placebo-controlled studyLin Xiang, Guixia Wang, Yulei Zhuang, et al.
Journal of Affective Disorders|November 28, 2022
Protective role of antioxidant supplementation for depression and anxiety: A meta-analysis of randomized clinical trialsHuan Wang, Mengdi Jin, Mengtong Xie, et al.
Journal of Diabetes|July 23, 2014
Evaluation of different obesity indices as predictors of type 2 diabetes mellitus in a Chinese populationXianchao Xiao, Yujia Liu, Chenglin Sun, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 16, 2022
LncRNA Osilr9 coordinates promoter DNA demethylation and the intrachromosomal loop structure required for maintaining stem cell pluripotencyYanbo Zhu, Zi Yan, Changhao Fu, et al.
Journal of Diabetes Investigation|May 17, 2016
Ideal glycated hemoglobin cut-off points for screening diabetes and prediabetes in a Chinese populationYujia Liu, Xianchao Xiao, Chenglin Sun, et al.
Frontiers in Endocrinology|September 26, 2022
Development and validation of a nomogram for assessing risk of isolated high 2-hour plasma glucoseKan Sun, Xianchao Xiao, Lili You, et al.
Diabetes Care|November 9, 2023
Efficacy and Safety of Mazdutide in Chinese Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Phase 2 TrialBo Zhang, Zhifeng Cheng, Ji Chen, et al.
The Lancet. Diabetes & Endocrinology|May 9, 2018
Dorzagliatin monotherapy in Chinese patients with type 2 diabetes: a dose-ranging, randomised, double-blind, placebo-controlled, phase 2 studyDalong Zhu, Shenglian Gan, Yu Liu, et al.
Journal of Epidemiology and Community Health|January 8, 2022
Association of education levels with the risk of hypertension and hypertension control: a nationwide cohort study in Chinese adultsKan Sun, Diaozhu Lin, Mian Li, et al.
Pageof 26